326 related articles for article (PubMed ID: 17786304)
1. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
2. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
3. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
4. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
[TBL] [Abstract][Full Text] [Related]
5. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
7. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.
Matsuda Y; Yoshimura H; Ueda J; Naito Z; Korc M; Ishiwata T
Am J Pathol; 2014 Mar; 184(3):674-85. PubMed ID: 24412093
[TBL] [Abstract][Full Text] [Related]
8. Metastatic-associated biological properties and differential gene expression profiles in established highly liver and peritoneal metastatic cell lines of human pancreatic cancer.
Ohno K; Hata F; Nishimori H; Yasoshima T; Yanai Y; Sogahata K; Ezoe E; Tanaka H; Kamiguchi K; Isomura H; Denno R; Sato N; Hirata K
J Exp Clin Cancer Res; 2003 Dec; 22(4):623-31. PubMed ID: 15053306
[TBL] [Abstract][Full Text] [Related]
9. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
10. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
12. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
13. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
14. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
15. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
16. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity.
Nishime C; Kawai K; Yamamoto T; Katano I; Monnai M; Goda N; Mizushima T; Suemizu H; Nakamura M; Murata M; Suematsu M; Wakui M
J Immunol; 2015 Aug; 195(4):1883-90. PubMed ID: 26170385
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: clinical and experimental studies.
Takamori H; Hiraoka T; Yamamoto T
Hepatogastroenterology; 1996; 43(9):748-55. PubMed ID: 8799425
[TBL] [Abstract][Full Text] [Related]
18. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
19. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells.
Sekine H; Chen N; Sato K; Saiki Y; Yoshino Y; Umetsu Y; Jin G; Nagase H; Gu Z; Fukushige S; Sunamura M; Horii A
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):214-9. PubMed ID: 23085231
[TBL] [Abstract][Full Text] [Related]
20. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
